These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

172 related items for PubMed ID: 1356604

  • 1. Long-acting beta 2-agonists.
    Tattersfield AE.
    Clin Exp Allergy; 1992 Jun; 22(6):600-5. PubMed ID: 1356604
    [No Abstract] [Full Text] [Related]

  • 2. Clinical pharmacology of long-acting beta-receptor agonists.
    Tattersfield AE.
    Life Sci; 1993 Jun; 52(26):2161-9. PubMed ID: 8099697
    [Abstract] [Full Text] [Related]

  • 3. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I, Lipworth BJ.
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacological similarities and differences between beta2-agonists.
    Lötvall J.
    Respir Med; 2001 Aug; 95 Suppl B():S7-11. PubMed ID: 11534896
    [Abstract] [Full Text] [Related]

  • 8. Alternative mechanisms for long-acting beta(2)-adrenergic agonists in COPD.
    Johnson M, Rennard S.
    Chest; 2001 Jul; 120(1):258-70. PubMed ID: 11451847
    [Abstract] [Full Text] [Related]

  • 9. Effects of prior treatment with salmeterol and formoterol on airway and systemic beta 2 responses to fenoterol.
    Grove A, Lipworth BJ.
    Thorax; 1996 Jun; 51(6):585-9. PubMed ID: 8693438
    [Abstract] [Full Text] [Related]

  • 10. Long-acting beta2-agonists: comparative pharmacology and clinical outcomes.
    van der Woude HJ, Aalbers R.
    Am J Respir Med; 2002 Jun; 1(1):55-74. PubMed ID: 14720076
    [Abstract] [Full Text] [Related]

  • 11. Formoterol and salmeterol in partially reversible chronic obstructive pulmonary disease: A crossover, placebo-controlled comparison of onset and duration of action.
    Celik G, Kayacan O, Beder S, Durmaz G.
    Respiration; 1999 Jun; 66(5):434-9. PubMed ID: 10516540
    [Abstract] [Full Text] [Related]

  • 12. Is there a need for another inhalative beta(2)-agonist besides formoterol in patients with asthma?
    Matthys H.
    Respiration; 2001 Jun; 68(4):432-7. PubMed ID: 11464097
    [Abstract] [Full Text] [Related]

  • 13. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM, Wenzel CL, Kradjan WA.
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [Abstract] [Full Text] [Related]

  • 14. Enhancement of inflammatory mediator release by beta(2)-adrenoceptor agonists in airway epithelial cells is reversed by glucocorticoid action.
    Holden NS, Rider CF, Bell MJ, Velayudhan J, King EM, Kaur M, Salmon M, Giembycz MA, Newton R.
    Br J Pharmacol; 2010 May; 160(2):410-20. PubMed ID: 20423350
    [Abstract] [Full Text] [Related]

  • 15. Formoterol on airway smooth muscle and human lung mast cells: a comparison with salbutamol and salmeterol.
    Nials AT, Ball DI, Butchers PR, Coleman RA, Humbles AA, Johnson M, Vardey CJ.
    Eur J Pharmacol; 1994 Jan 14; 251(2-3):127-35. PubMed ID: 8149969
    [Abstract] [Full Text] [Related]

  • 16. Duration of action of inhaled vs. Intravenous beta(2)-adrenoceptor agonists in an anaesthetized guinea-pig model.
    Mohammed SP, Taylor CV, Weyman-Jones CB, Mather ME, Vendy K, Dougall IG, Young A.
    Pulm Pharmacol Ther; 2000 Jan 14; 13(6):287-92. PubMed ID: 11061983
    [Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic and pharmacodynamic aspects of salmeterol therapy.
    Buchwald A, Hochhaus G.
    Int J Clin Pharmacol Ther; 1998 Dec 14; 36(12):652-60. PubMed ID: 9877002
    [Abstract] [Full Text] [Related]

  • 18. Relaxation kinetics of formoterol and salmeterol in the guinea pig trachea in vitro.
    Anderson P, Lötvall J, Lindén A.
    Lung; 1996 Dec 14; 174(3):159-70. PubMed ID: 8830192
    [Abstract] [Full Text] [Related]

  • 19. Long-acting beta agonists in asthma therapy.
    Rissmiller RW, Larj MJ, Peters SP.
    Curr Allergy Asthma Rep; 2004 Mar 14; 4(2):91-2. PubMed ID: 14769255
    [No Abstract] [Full Text] [Related]

  • 20. Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells.
    Chu YT, Chang TT, Jong YJ, Kuo PL, Lee HM, Lee MS, Chang HW, Hung CH.
    Pediatr Allergy Immunol; 2010 Mar 14; 21(2 Pt 1):345-52. PubMed ID: 20003162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.